<DOC>
	<DOCNO>NCT01678053</DOCNO>
	<brief_summary>Vocal process granuloma inflammatory mass cause part vocal trauma arise posterior aspect vocal fold result throat pain , difficulty swallowing , hoarseness , globus sensation . Antireflux therapy treat granulomas , many recalcitrant therapy take month year resolve . Botulinum toxin injection thyroarytenoid muscle effectively employ recalcitrant granuloma , cause significant voice loss , occasional difficulty swallowing , clinical experience , associate significant recurrence . The investigator propose inject another muscle larynx call interarytenoid muscle botulinum toxin type A maintain benefit injection less loss voice . The investigator show effectiveness treatment small , retrospective analysis .</brief_summary>
	<brief_title>Efficacy Study Botulinum Toxin ( BOTOX ) Injections Treat Vocal Fold Granulomas</brief_title>
	<detailed_description>Vocal fold granuloma may due reflux , voice trauma , intubation , multiple unknown etiology . Regimens voice therapy anti-reflux medication show resolution rate vary 38 % 100 % , recurrence rate 15-20 % , 50-92 % surgical-operated recalcitrant granuloma . Nasri colleague first propose thyroarytenoid botulinum toxin type A ( BOTOX ) injection vocal fold granuloma success . They posit chemically paralyzed muscle would result limited contact site granuloma , allow heal . Damrose Damrose show thyroarytenoid BOTOX injection effective treat recalcitrant vocal fold granuloma . Both group note hoarseness expect side effect . Pham colleague show complete resolution granulomas 2-8 week treatment thyroarytenoid BOTOX injection . This compare mean granuloma resolution 5.7 month proton pump inhibitor therapy alone . The investigator review eight patient treat recalcitrant vocal fold granuloma Mass Eye Ear interarytenoid BOTOX injection find serious adverse effect complete response seven case . The investigator seek compare interarytenoid BOTOX injection standard anti-reflux therapy alone see addition IA Botox injection improve response rate 3 month . The investigator choose timeframe since 86 % granuloma treat retrospective study resolve 3 month initiation treatment compare 25 % granuloma treat medical management . The investigator include Thyroarytenoid injection arm study technique useful clinical experience . For consent , Voice Handicap Index survey ( 6 - see attach ) complete . Participants randomize undergo medical therapy omeprazole ( 40mg mouth twice daily ) interarytenoid BOTOX injection follow reflux regimen . Randomization perform Tufts online randomization plan , may find : http : //www.tufts.edu/~gdallal/PLANDOC.HTM . This program generate random order participant enrol either two arm study . The injection consist 10 unit botulinum toxin inject interarytenoid muscle fiberoptic visualization . All participant remain PPI therapy duration study . Participants receive prescription PPI medication attend Laryngologist participant responsible acquire take medication . Injections perform per standard MEEI Laryngology protocol interarytenoid BOTOX injection . Participants evaluate 1.5 month , 3 month 6 month fiberoptic examination well Voice Handicap Index &amp; Reflux Symptom Index . Participants medication arm continue granuloma 3 month receive BOTOX injection . They re-evaluated 3 month injection . Examinations record review blinded reviewer .</detailed_description>
	<mesh_term>Granuloma</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<mesh_term>Granuloma , Laryngeal</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>adult age 18 year old old vocal fold granuloma willing attend followup appointment pregnant female woman nurse minor patient unable give inform consent patient take Plavix patient : impaired laryngeal motion result neurological impairment vocal fold immobility preexist oropharyngeal swallow problem history radiation therapy history aspiration pneumonia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Botulinum Toxins , Type A</keyword>
</DOC>